Specify Company / Ticker to Get the Summary
Dividend History CNSP
Dividend Analytics CNSP
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Cns Pharmaceuticals Inc
CNSPCNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas. Address: 2100 West Loop South, Houston, TX, United States, 77027
Analytics
WallStreet Target Price
7.00 USDP/E Ratio
–Dividend Yield
–Financials CNSP
Results | 2019 | Dynamics |